Edition:
India

Arrowhead Pharma Earns $20 Mln Payment From Amgen For Start Of Trial Of AMG 890


Wednesday, 29 Jul 2020 

July 29 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS EARNS $20 MILLION MILESTONE PAYMENT FROM AMGEN FOR START OF PHASE 2 TRIAL OF AMG 890.ARROWHEAD PHARMACEUTICALS - EARNED $20 MILLION MILESTONE PAYMENT FROM AMGEN FOLLOWING ADMINISTRATION OF FIRST DOSE OF AMG 890 IN PHASE 2 CLINICAL STUDY.